RK

Rahul Kothari

Active Director Director DIN 08419942
DIN 08419942 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Rahul Kothari

Data last updated:

Rahul Kothari is a Director at Pharmadeal Private Limited (since 2019). The company operates in Pharma. Pharmadeal Private Limited reported revenue of ₹81.6 Lakh (FY 2021).

DIN 08419942
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2019
Oldest Company Age 48 yrs
Largest company Pharmadeal Private Limited · ₹81.6 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmadeal Private Limited U02423MP1978PTC001431
Director11 Apr 20191978₹81.6 Lakh (FY 2021)Active

Board colleagues of Rahul Kothari

NameDINCompanyDesignation
Nitin Tiwari01644064Pharmadeal Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmadeal Private Limited
Premium access

Shareholding and investment profile for Rahul Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Kothari

Rahul Kothari currently holds 1 directorship: Pharmadeal Private Limited (Director, since 11 Apr 2019, revenue ₹81.6 Lakh (FY 2021)).

Rahul Kothari was first appointed on 11 Apr 2019 as Director at Pharmadeal Private Limited.

The current boards of Rahul Kothari's companies include Nitin Tiwari (Pharmadeal Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available